| 名稱(chēng) | KRAS G12C-R68M/BaF3 Kinase |
| 型號(hào) | CBP73372 |
| 報(bào)價(jià) |  |
| 特點(diǎn) | KRAS G12C-R68M/BaF3 Kinase |
產(chǎn)品搜索
產(chǎn)品分類(lèi)
相關(guān)文章
- PTPRZ1-MET腦膠質(zhì)瘤分子診斷標(biāo)準(zhǔn)品上新
- STEAP1/2的細(xì)胞模型
- CSF3R細(xì)胞篩選模型
- 羅氏免疫療法獲FDA批準(zhǔn)治療晚期非小細(xì)胞肺癌（NSCLC）
- RET基因如何檢測(cè)？
- 從“腫瘤免疫療法”發(fā)展，看“單抗、CAR-T”任重而道遠(yuǎn)！
- 耐藥ATCC細(xì)胞株如何構(gòu)建看完就會(huì)知道
- 上海生科院發(fā)現(xiàn)PKM2抑制細(xì)胞凋亡的新機(jī)制
- Science：腫瘤非整倍體與癌癥免疫療法反應(yīng)下降相關(guān)聯(lián)
- 肥胖與腫瘤治療新星靶點(diǎn)——GDF15-GFRAL
聯(lián)系我們
聯(lián)系人：蔣經(jīng)理
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
電話(huà)：4008750250
號(hào)碼：
手機(jī)：18066071954
地址：南京市棲霞區(qū)緯地路9號(hào)
Email： zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73372KRAS G12C-R68M/BaF3 Kinase
- 詳細(xì)內(nèi)容
| CBP73372 | |
| I. Introduction | |
Cell Line Name： | KRAS G12C-R68M/BaF3 |
Host Cell: | Ba/F3 |
| Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS+2ug/ml puromycin |
Mycoplasma Status: | Negative |
| II.Background | |
KRAS, KRAS proto-oncogene, GTPase, is a member of the small GTPase superfamily and a key regulator of the MAPK, PI3K/AKT/mTOR pathways (PMID: 23622131). KRAS mutations are identified in a wide range of cancers (PMID: 28666118). | |
| III. Representative Data | |
1.Sanger of KRAS G12C-R68M/BaF3
Figure 1. KRAS(NM_033360.4):c.34G>T p.G12C
Figure 2. KRAS(NM_004985.5): c.203G>T p.R68M | |
2. Anti-proliferation assay
Figure 3. CTG Proliferation Assay of KRAS G12C/R68M BaF3 Cells (C2). | |
會(huì)員_a.png)